Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push

reuters.com/business/healthcare-pharmaceuticals/novo-nordisk-signs-up-21-billion-licensing-deal-with-omeros-rare-disease-push-2025-10-15

This story appeared on reuters.com, 2025-10-15 12:35:09.451000.
The Entire Business World on a Single Page. Free to Use →